Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 19681038)

Published in J Cell Biochem on October 15, 2009

Authors

Mathew J Joseph1, Surabhi Dangi-Garimella, Mario A Shields, Michelle E Diamond, Limin Sun, Jennifer E Koblinski, Hidayatullah G Munshi

Author Affiliations

1: Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

Articles citing this

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol (2010) 2.75

Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol (2012) 1.60

Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. J Biol Chem (2011) 1.35

Retracted Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest (2011) 1.26

Establishing neural crest identity: a gene regulatory recipe. Development (2015) 1.22

Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One (2011) 1.14

Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins. J Biol Chem (2012) 1.12

Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res (2010) 1.11

The skinny on Slug. Mol Carcinog (2010) 1.06

Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma. Int J Cancer (2011) 1.04

Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling. Oncogene (2013) 1.03

Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol (2011) 0.99

Slug expression during melanoma progression. Am J Pathol (2012) 0.97

Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med (2012) 0.92

Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J Biol Chem (2010) 0.90

β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling. PLoS One (2013) 0.87

TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways. PLoS One (2013) 0.80

Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells. J Cell Biochem (2011) 0.80

MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma. BMC Cancer (2015) 0.79

Foxn1 Transcription Factor Regulates Wound Healing of Skin through Promoting Epithelial-Mesenchymal Transition. PLoS One (2016) 0.77

Snail2 promotes osteosarcoma cell motility through remodelling of the actin cytoskeleton and regulates tumor development. Cancer Lett (2013) 0.77

miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. J Cancer Sci Ther (2016) 0.77

Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model. World J Gastroenterol (2016) 0.75

Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway. Oncol Lett (2015) 0.75

Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis. Kidney Res Clin Pract (2016) 0.75

EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration. J Clin Med (2016) 0.75

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Onco Targets Ther (2017) 0.75

Articles by these authors

TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst (2014) 2.08

Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy. Oncology (Williston Park) (2010) 2.07

Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem (2004) 1.49

Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer (2008) 1.48

Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res (2010) 1.46

Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res (2010) 1.38

Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. J Biol Chem (2011) 1.35

Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochem J (2012) 1.33

Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression. J Surg Res (2011) 1.31

Nanocomposite containing amorphous calcium phosphate nanoparticles for caries inhibition. Dent Mater (2011) 1.29

Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res (2006) 1.27

Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res (2008) 1.19

Mechanical and acid neutralizing properties and bacteria inhibition of amorphous calcium phosphate dental nanocomposite. J Biomed Mater Res B Appl Biomater (2011) 1.18

Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem (2003) 1.14

Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice. Cancer Res (2011) 1.13

Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins. J Biol Chem (2012) 1.12

Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. J Biol Chem (2010) 1.12

Strength and fluoride release characteristics of a calcium fluoride based dental nanocomposite. Biomaterials (2008) 1.12

Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Res (2009) 1.10

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Mol Cancer Ther (2006) 1.09

Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol (2009) 1.08

Nanocomposites with Ca and PO4 release: effects of reinforcement, dicalcium phosphate particle size and silanization. Dent Mater (2007) 1.04

Calcium and phosphate ion releasing composite: effect of pH on release and mechanical properties. Dent Mater (2008) 1.01

MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling. Mol Cancer Res (2011) 1.00

Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res (2008) 0.99

Combinatorial screening of osteoblast response to 3D calcium phosphate/poly(ε-caprolactone) scaffolds using gradients and arrays. Biomaterials (2010) 0.98

Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut (2012) 0.97

Injectable calcium phosphate cement: effects of powder-to-liquid ratio and needle size. J Biomed Mater Res B Appl Biomater (2008) 0.97

Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci (2008) 0.95

Deficits in high- (>60 Hz) gamma-band oscillations during visual processing in schizophrenia. Front Hum Neurosci (2013) 0.94

Angiogenic laminin-derived peptides stimulate wound healing. Int J Biochem Cell Biol (2008) 0.91

Patterns in cortical connectivity for determining outcomes in hand function after subcortical stroke. PLoS One (2012) 0.91

Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J Biol Chem (2010) 0.90

Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Mol Cancer Res (2009) 0.89

Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma. Cancer (2002) 0.89

Snail cooperates with KrasG12D to promote pancreatic fibrosis. Mol Cancer Res (2013) 0.88

Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. J Biol Chem (2004) 0.87

Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem (2006) 0.87

Nanofiber scaffold gradients for interfacial tissue engineering. J Biomater Appl (2012) 0.87

Chronic PKC-beta activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane current generation. Am J Physiol Gastrointest Liver Physiol (2006) 0.86

Effects of incorporating nanosized calcium phosphate particles on properties of whisker-reinforced dental composites. J Biomed Mater Res B Appl Biomater (2007) 0.85

Three-dimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression. PLoS One (2013) 0.83

Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med (2010) 0.82

Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients. Expert Rev Anticancer Ther (2011) 0.82

Laminin-111-derived peptides and cancer. Cell Adh Migr (2012) 0.82

Functional reorganization associated with outcome in hand function after stroke revealed by regional homogeneity. Neuroradiology (2013) 0.82

Contribution of epithelial-mesenchymal transition to pancreatic cancer progression. Cancers (Basel) (2010) 0.82

Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking. Biochem J (2007) 0.81

The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells. Clin Exp Metastasis (2008) 0.80

Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells. J Cell Biochem (2011) 0.80

Development of a nonrigid, durable calcium phosphate cement for use in periodontal bone repair. J Am Dent Assoc (2006) 0.79

Effect of filler level and particle size on dental caries-inhibiting Ca-PO(4) composite. J Mater Sci Mater Med (2009) 0.78

Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis. BMC Cancer (2014) 0.78

Chronic PKC-beta2 activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane CFTR targeting. Am J Physiol Gastrointest Liver Physiol (2006) 0.78

Mne-X: MEG/EEG Real-Time Acquisition, Real-Time Processing, and Real-Time Source Localization Framework. Biomed Tech (Berl) (2013) 0.78

FDA grants accelerated approval for ibrutinib for CLL. Am J Manag Care (2014) 0.78

Metabolic profiling reveals disorder of carbohydrate metabolism in mouse fibroblast cells induced by titanium dioxide nanoparticles. J Appl Toxicol (2012) 0.77

Column bioleaching of uranium embedded in granite porphyry by a mesophilic acidophilic consortium. Bioresour Technol (2011) 0.77

Altered topological properties of the cortical motor-related network in patients with subcortical stroke revealed by graph theoretical analysis. Hum Brain Mapp (2013) 0.77

Identification of prosaposin as a novel interaction partner for Rhox5. J Genet Genomics (2007) 0.77

Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells. Cell Physiol Biochem (2013) 0.76

Electroacupuncture suppresses discrete cue-evoked heroin-seeking and fos protein expression in the nucleus accumbens core in rats. Evid Based Complement Alternat Med (2012) 0.76

A big step forward in treating chronic diabetic foot ulcers. Am J Manag Care (2014) 0.75

The nanoscale phase distinguishing of PCL-PB-PCL blended in epoxy resin by tapping mode atomic force microscopy. Nanoscale Res Lett (2012) 0.75

Adjuvant pre- or post-operative chemotherapy does not improve survival in rectal cancer. Am J Manag Care (2014) 0.75

Low Serum-Butyrylcholinesterase Activity as a Prognostic Marker of Mortality Associates with Poor Cardiac Function in Acute Myocardial Infarction. Clin Lab (2016) 0.75

[Role of high resolution CT in diffuse pulmonary nodules]. Zhonghua Zhong Liu Za Zhi (2002) 0.75

Early cellular aging: salt and the telomeres. Am J Manag Care (2014) 0.75

[Production and mechanism of CCL5 by macrophages in U14 cervical cancer-bearing mice during infection]. Zhonghua Fu Chan Ke Za Zhi (2015) 0.75

[Adaptability of Litopenaeus vannamei to saline-alkali water in west Jilin Province]. Ying Yong Sheng Tai Xue Bao (2006) 0.75

Reducing risk and improving efficacy of clinical trials: the adaptive design. Am J Manag Care (2014) 0.75

Synthesis and cytotoxic evaluation of novel N-methyl-4-phenoxypicolinamide derivatives. Molecules (2011) 0.75

Environmental pollutants: a risk factor for obesity and diabetes. Am J Manag Care (2014) 0.75

New studies affirm Mediterranean diet's potential for patient self-management, prevention of T2DM. Am J Manag Care (2014) 0.75

How do you establish value in cancer care? Am J Manag Care (2014) 0.75

Comparative effectiveness in esophagogastric cancer. Cancer Treat Res (2015) 0.75

Q&A with Syapse CEO Ken Tarkoff. Am J Manag Care (2017) 0.75

A new method to fight cancer: the body's own immune system. Am J Manag Care (2014) 0.75

USPSTF recommends BRCA testing in women based on familial history. Am J Manag Care (2014) 0.75

New orphan drug in the T1DM realm: another immunotherapy success story? Am J Manag Care (2014) 0.75